← Back to Search

Functional Mapping

Intracranial Stimulation Mapping for Epilepsy

N/A
Recruiting
Led By Alexander Herman, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Persons who are rendered temporarily or permanently invulnerable by inability to understand the research due to study complexity, cognitive impairment, or by inability to make independent decisions owing to University of Minnesota or to Fairview health services
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after stimulation sessions
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers learn more about how epilepsy affects the brain, which could lead to better treatments for the condition.

Who is the study for?
This trial is for adults over 18 with epilepsy who are already getting intracranial EEG monitoring at the University of Minnesota/MINCEP program. They must understand the study, agree to all procedures, and be available throughout. Pregnant individuals or those unable to make independent decisions due to cognitive impairments are excluded.
What is being tested?
The study is testing a new way to create brain maps in adult patients with partial epilepsy. These maps aim to pinpoint where in the brain seizures start and how different regions communicate during a seizure.
What are the potential side effects?
Since this trial involves functional mapping during an already planned EEG monitoring procedure, side effects may include typical risks associated with EEG such as discomfort at electrode sites but specific side effects will depend on individual patient conditions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to understand and make decisions about participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after stimulation sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after stimulation sessions for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Electrical Stimulation of the Brain

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Research IESMExperimental Treatment1 Intervention
Functional mapping for research application

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,434 Previous Clinical Trials
1,621,672 Total Patients Enrolled
13 Trials studying Epilepsy
541 Patients Enrolled for Epilepsy
Alexander Herman, MDPrincipal InvestigatorUMN

Media Library

Intracranial Stimulation Mapping (Functional Mapping) Clinical Trial Eligibility Overview. Trial Name: NCT05290610 — N/A
Epilepsy Research Study Groups: Research IESM
Epilepsy Clinical Trial 2023: Intracranial Stimulation Mapping Highlights & Side Effects. Trial Name: NCT05290610 — N/A
Intracranial Stimulation Mapping (Functional Mapping) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05290610 — N/A
~11 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top